Id: | acc0526 |
Group: | 1sens |
Protein: | AMPK |
Gene Symbol: | PRKAA2 |
Protein Id: | P54646 |
Protein Name: | AAPK2_HUMAN |
PTM: | phosphorylation |
Site: | Thr172 |
Site Sequence: | MMSDGEFLRTSCGSPNYAAPE |
Disease Category: | Cancer |
Disease: | Pancreas Cancer |
Disease Subtype: | |
Disease Cellline: | MIA PaCa-2 |
Disease Info: | |
Drug: | 2-Deoxy-d-glucose |
Drug Info: | "2-Deoxy-D-glucose (2-DG) is a glucose analog that inhibits glycolysis by interfering with glucose metabolism, and it has been investigated for its potential in cancer therapy, viral infections, and metabolic diseases due to its ability to disrupt energy production in rapidly proliferating cells." |
Effect: | modulate |
Effect Info: | "2-Deoxy-d-glucose increases the phosphorylation of GFAT1 and AMPK, resulting in endoplasmic reticulum-related apoptosis." |
Note: | |
Score: | 4.0 |
Pubmed(PMID): | 29753740 |
Sentence Index: | 29753740_0 |
Sentence: | 2-Deoxy-d-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic cancer cells. |
Sequence & Structure:
MAEKQKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPEDPSYDANVIDDEAVKEVCEKFECTESEVMNSLYSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMHIPPGLKPHPERMPPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNAYHLRVRRKNPVTGNYVKMSLQLYLVDNRSYLLDFKSIDDEVVEQRSGSSTPQRSCSAAGLHRPRSSFDSTTAESHSLSGSLTGSLTGSTLSSVSPRLGSHTMDFFEMCASLITTLAR
Select PDB:
Target | Drug name | MOA | Phase | Status | Disease | Source |
---|---|---|---|---|---|---|
PRKAA2 | ACADESINE | AMP-activated protein kinase, AMPK activator | 3 | - | cardiovascular disease | ATC |
PRKAA2 | ACADESINE | AMP-activated protein kinase, AMPK activator | 1 | Completed | chronic lymphocytic leukemia | ClinicalTrials |
Note: Only show clinically investigational or approved drugs with protein targets.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACPRKAA2-Thr172 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | 0.934 |
HGSC | -1.055 |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | 0.121 |
PDAC | |
UCEC |
PTM-Disease Association:
source: PTMDNo data.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.